Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Capsules
Patent
1988-05-03
1990-09-04
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Capsules
424464, A61K 920
Patent
active
049543474
ABSTRACT:
A pharmaceutical composition for the treatment of cardiac arrhythmia comprising an effective amount of propafenone in combination with a subtherapeutic amount of quinidine, such that the quinidine potentiates the elimination half-life of the propafenone.
The invention also comprises a method for treating patients with cardiac arrhythmia by means of administering said pharmaceutical composition.
REFERENCES:
patent: 4460605 (1984-07-01), Petrik et al.
patent: 4557934 (1985-10-01), Cooper et al.
patent: 4612320 (1986-09-01), Franke et al.
Connolly et al., "Clin. Efficacy & Electrophysiology of Oral Propafenone for Vent. Tachycardia", Am. J. Card., vol. 52, pp. 1208-1213, (Dec. 1983).
Siddoway et al., "Polymorphic Oxidative Metabolism of Propafenone in Man", Circulation 68, (Supp. III), p. 64, (Oct. 1983).
Otton et al., "Competitive Inhibition of Sparteine Oxidation in Human Liver . . . ", Life Sciences, vol. 34, pp. 73-80, (1984).
Leeman et al., "Single-Dose Quinidine Treatment Inhibits Metaprolol Oxidation in Extensive Metabolizers", Eur. J. Clin. Pharmocol., 29:739-741, (1986).
Klein et al., "Enhanced Antiarrhythmic Efficacy of Propafenone When Used in Combination with Procainamide or Quinidine", Am. Heart J., (Sep. 1987), pp. 551-558.
Guerrero Juan R.
Kristen Edward B.
BASF K & F Corp.
Horne Leon R.
Page Thurman K.
LandOfFree
Long lasting composition of propafenone and quinidine for treatm does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Long lasting composition of propafenone and quinidine for treatm, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Long lasting composition of propafenone and quinidine for treatm will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-440724